News | May 05, 2026
Silent cough, deadly risk: Doctors warn of hidden asthma surge amid rising pollution
Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses
Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
Leading orthopaedic experts call for equitable insurance coverage to patients for accessing advanced, precision-driven joint replacement technologies
The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations
The Danish biotech company confirmed the global study will begin in the second half of 2026
After Phase 3 results show major hair regrowth gains
The aim is to simplify and strengthen long-term control of airway disease through triple therapy in one device
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
The submission is backed by positive results from the Phase 3 AFFIRM study
India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle
Subscribe To Our Newsletter & Stay Updated
